fda stops semaglutide compounding Compounded is not the same as FDA-approved. The has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before Compounded Semaglutide: Legal & Safe
Description
For composite kidney outcomes, the HR was 0.52 (95% CI 0.330.83) with SGLT2is and 0.70 (95% CI 0.590.83) without SGLT2is ( P -value for interaction 0.38) (Table 3)
Some pharmacies assign a Beyond-Use Date (BUD) of 30 to 90 days from the date of compounding, but this timeline assumes constant refrigeration
Sensitivity analysis 3 used the results from the treatmentregimen estimand in both trials (referred to as the treatment policy estimand in SUSTAIN FORTE), which were only available for the full population in both trials
Table 3
But again, youll likely still need to come in for some testing
